These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32781184)

  • 41. Treatment of palmar hyperhidrosis with botulinum neurotoxin a.
    Mannava S; Mannava KA; Nazir OF; Plate JF; Smith BP; Koman LA; Tuohy CJ
    J Hand Surg Am; 2013 Feb; 38(2):398-400. PubMed ID: 23267759
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of botulinum toxin in stellate ganglion for craniofacial hyperhidrosis: a case report.
    Park JH; Kim R; Na SH; Kwon SY
    J Int Med Res; 2021 Mar; 49(3):3000605211004213. PubMed ID: 33788638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of Miniuniportal Video-Assisted Thoracoscopic Selective Sympathectomy (Ramicotomy) for the Treatment of Severe Palmar and Axillar Hyperhidrosis.
    Akil A; Semik M; Fischer S
    Thorac Cardiovasc Surg; 2019 Aug; 67(5):415-419. PubMed ID: 29739022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interventions for hyperhidrosis in secondary care: a systematic review and value-of-information analysis.
    Wade R; Rice S; Llewellyn A; Moloney E; Jones-Diette J; Stoniute J; Wright K; Layton AM; Levell NJ; Stansby G; Craig D; Woolacott N
    Health Technol Assess; 2017 Dec; 21(80):1-280. PubMed ID: 29271741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Techniques to Relieve Pain Associated With Botulinum Injections for Palmar and Plantar Hyperhidrosis.
    Nasser S; Farshchian M; Kimyai-Asadi A; Potts GA
    Dermatol Surg; 2021 Dec; 47(12):1566-1571. PubMed ID: 34743126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval.
    Wollina U; Karamfilov T; Konrad H
    J Am Acad Dermatol; 2002 Apr; 46(4):536-40. PubMed ID: 11907503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
    Naumann M; Lowe NJ
    BMJ; 2001 Sep; 323(7313):596-9. PubMed ID: 11557704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study.
    Saadia D; Voustianiouk A; Wang AK; Kaufmann H
    Neurology; 2001 Dec; 57(11):2095-9. PubMed ID: 11739832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic review.
    Cruddas L; Baker DM
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):952-963. PubMed ID: 27976476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of microwave ablation, botulinum toxin injection, and liposuction-curettage in the treatment of axillary hyperhidrosis: A systematic review.
    Nasr MW; Jabbour SF; Haber RN; Kechichian EG; El Hachem L
    J Cosmet Laser Ther; 2017 Feb; 19(1):36-42. PubMed ID: 27782761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin B in the treatment of craniofacial hyperhidrosis.
    Karlqvist M; Rosell K; Rystedt A; Hymnelius K; Swartling C
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1313-7. PubMed ID: 24118460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of only T3 and T3-T4 sympathectomy for axillary hyperhidrosis regarding treatment effect and compensatory sweating.
    Yuncu G; Turk F; Ozturk G; Atinkaya C
    Interact Cardiovasc Thorac Surg; 2013 Aug; 17(2):263-7. PubMed ID: 23644731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C-Arm Guided Percutaneous Radiofrequency Thoracic Sympathectomy for Treatment of Primary Palmar Hyperhidrosis in Comparison with Local Botulinum Toxin Type A Injection, Randomized Trial.
    Mostafa TAH; Hamed AA; Mohammed BM; El Sheikh NA; Shama AAA
    Pain Physician; 2019 Nov; 22(6):591-599. PubMed ID: 31775406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary hyperhidrosis: Implications on symptoms, daily life, health and alcohol consumption when treated with botulinum toxin.
    Shayesteh A; Boman J; Janlert U; Brulin C; Nylander E
    J Dermatol; 2016 Aug; 43(8):928-33. PubMed ID: 26875781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postmenopausal craniofacial hyperhidrosis treated with botulinum toxin type B.
    Cabreus P; Swartling C; Rystedt A
    J Dermatol; 2019 Oct; 46(10):874-878. PubMed ID: 31373068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperhidrosis: Management Options.
    McConaghy JR; Fosselman D
    Am Fam Physician; 2018 Jun; 97(11):729-734. PubMed ID: 30215934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.
    Lakraj AA; Moghimi N; Jabbari B
    Toxins (Basel); 2013 Apr; 5(4):821-40. PubMed ID: 23612753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis.
    Glaser DA; Pariser DM; Hebert AA; Landells I; Somogyi C; Weng E; Brin MF; Beddingfield F
    Pediatr Dermatol; 2015; 32(5):609-17. PubMed ID: 26059781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Axillary hyperhidrosis: treatment with botulinum toxin A.
    Odderson IR
    Arch Phys Med Rehabil; 1998 Mar; 79(3):350-2. PubMed ID: 9523792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.